{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:15:11Z","timestamp":1769915711485,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Multisystem inflammatory syndrome in children (MIS-C) is a pathologic condition that has emerged during the coronavirus disease 2019 (COVID-19) pandemic. Although the epidemiological evidence of association between MIS-C and SARS-CoV-2 infection has been demonstrated, its pathogenic mechanism is still undefined. We describe the case of a 17-year old female, previously vaccinated against SARS-CoV-2, presenting with a history of asthenia, fever, cough, anorexia, abdominal pain, and vomiting. During the hospitalization, the patient developed bilateral conjunctivitis, hand vasculitis, cutaneous rash, and multiple pulmonary nodules, following by hepatitis and pancreatitis. As she reported a high-risk contact with a SARS-CoV-2 positive patient 10 days before admission, the epidemiological link and the clinical picture characterized by multi-system organ disfunction and inflammatory biomarkers increase led us to the diagnosis of MIS-C. Therefore, the patient was treated with intravenous immunoglobulin and corticosteroids, resulting in a rapid resolution of fever, cutaneous, and pulmonary involvement, while the recovery of hepatitis and pancreatitis was observed in the following weeks. This case leads to the discussion on whether SARS-CoV-2 immunized children and adolescents should be considered at risk of developing MIS-C and on their possible presentation with non-classic clinical features. Additionally, due to the increasing number of vaccinated children and adolescents, the issues resulting either from the diagnostic suspect of MIS-C or from the consequent need of an early therapeutic approach are discussed.<\/jats:p>","DOI":"10.3389\/fped.2022.896903","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:50:40Z","timestamp":1652680240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent \u2013 A Critical Reasoning"],"prefix":"10.3389","volume":"10","author":[{"given":"Rita","family":"Consolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Colombatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Bonuccelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizia R.","family":"Brunetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego G.","family":"Peroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents.","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19.","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review.","volume":"226","author":"Abrams","year":"2020","journal-title":"J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1002\/art.41616","article-title":"American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2.","volume":"73","author":"Henderson","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years \u2013 United States, July-December 2021.","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.2021.23262","article-title":"Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France.","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100283","article-title":"Serologic response to COVID-19 infection and\/or vaccine in cancer patients on active treatment.","volume":"6","author":"Grinshpun","year":"2021","journal-title":"ESMO Open."},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.","volume":"22","author":"Weisberg","year":"2021","journal-title":"Nat Immunol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640093","article-title":"Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies.","volume":"12","author":"Ricke","year":"2021","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/iid3.404","article-title":"Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.","volume":"9","author":"Costagliola","year":"2021","journal-title":"Immun Inflamm Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/jpids\/piaa142","article-title":"Immunological assessment of pediatric multisystem inflammatory syndrome related to coronavirus disease 2019.","volume":"10","author":"Grazioli","year":"2021","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab936","article-title":"Multisystem inflammatory syndrome in adults after SARS-CoV-2 infection and COVID-19 vaccination.","author":"Belay","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01724-3","article-title":"Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.","author":"Sacco","year":"2022","journal-title":"Nat Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211381","article-title":"TIM3+ TRBV11-2 T cells and IFN\u03b3 signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.","volume":"219","author":"Hoste","year":"2022","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146614","article-title":"HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.","volume":"131","author":"Porritt","year":"2021","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243888","article-title":"Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V).","volume":"14","author":"Nune","year":"2021","journal-title":"BMJ Case Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/INF.0000000000003432","article-title":"A case of multisystem inflammatory syndrome in a 12-year-old male after COVID-19 mRNA vaccine.","volume":"41","author":"Yalcinkaya","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247176","article-title":"Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination.","volume":"15","author":"Wangu","year":"2022","journal-title":"BMJ Case Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1097\/INF.0000000000003444","article-title":"Multisystem inflammatory syndrome in a previously vaccinated adolescent female with sickle cell disease.","volume":"41","author":"DeJong","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.867968","article-title":"Caregivers\u2019 attitudes toward COVID-19 vaccination in children and adolescents with a history of SARS-CoV-2 infection.","volume":"10","author":"Buonsenso","year":"2022","journal-title":"Front Pediatr."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-018242","article-title":"Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C).","volume":"146","author":"Rostad","year":"2020","journal-title":"Pediatrics."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.896903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:50:43Z","timestamp":1652680243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.896903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":22,"alternative-id":["10.3389\/fped.2022.896903"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.896903","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"896903"}}